| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2025 | Jun 10, 2025 | Alkermes plc. | Director | Sell | 26.3 | -793 | -3.33% | ✗ | $25.1K |
| May 31, 2025 | Jun 2, 2025 | Alkermes plc. | Director | Sell | 22.5 | -1,924 | -8.58% | ✗ | $58.9K |
| Jun 29, 2024 | Jul 1, 2024 | Alkermes plc. | Director | Sell | 26.3 | -1,465 | -9.22% | ✗ | $35.3K |
| Jun 8, 2024 | Jun 10, 2024 | Alkermes plc. | Director | Sell | 26.3 | -793 | -7.50% | ✗ | $19K |
| Jul 7, 2023 | Jul 10, 2023 | Alkermes plc. | Director | Sell | 26.3 | -1,430 | -16.44% | ✗ | $42.7K |
| Jun 8, 2023 | Jun 12, 2023 | Alkermes plc. | Director | Sell | 26.3 | -867 | -22.28% | ✗ | $27.3K |
| Feb 25, 2021 | Mar 1, 2021 | Cyclerion Therapeutics, Inc. | Chief Medical Officer | Sell | 36.3 | -2,637 | -5.81% | ✓ | $10.5K |